| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 69 | 10.2x | 17.3x | Top tier | |
Growth | 34 | 2.5% | 7.1% | Bottom tier | |
Quality | 75 | — | — | Top tier | |
Safety | 88 | — | — | Top tier | |
Capital Return | 88 | 1.77% | 0.06% | Top tier | |
Momentum | 89 | 33.0% | -1.6% | Top tier | |
Sentiment | 21 | 2 | 3 | Bottom tier |
10-year US Treasury yield 4.96% as of 2026-10-22. Estimates computed from company data and analyst targets, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Enact Holdings Inc. operates in private mortgage insurance, insuring residential loans and generating revenue primarily from premiums on its in-force insurance portfolio, along with investment income and Enact Re operations. In fiscal Q2 2026, new insurance written totaled $15 billion, increasing primary insurance in force to $274 billion, while net premiums earned were $245 million and investment income was $73 million.
In fiscal Q2 2026, Enact reported adjusted operating income of $177 million and adjusted diluted earnings per share of $1.26, compared with $1.15 in fiscal Q2 2025. Adjusted operating return on equity was 13.2%, the loss ratio reached 14%, and the expense ratio was 21%, while EDGAR data for fiscal Q1 2026 showed revenue of $312.1 million and earnings per share of $1.18.
The business mix relies primarily on primary mortgage insurance, with additional contributions from Enact Re and investments. Primary insurance in force increased by approximately 2% year over year to $274 billion, net premiums earned remained stable year over year at $245 million, while investment income increased 11% year over year to $73 million, supported by a yield on new investments exceeding 5% and an increase in the average portfolio yield to 4.6%.
The average analyst price target is $46, which is also both the highest and lowest available target, with a neutral consensus; this target is below the 52-week range high of $50.56 and above its low of $34.64. No price-to-earnings multiple is available in the data, so the risk assessment centers on the neutral consensus and narrow target range, balanced against adjusted earnings-per-share growth and strong capital returns on one hand, and pressure on premium rates and the potential for higher delinquencies in the second half of fiscal 2026 on the other.
Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.
Enact generated income primarily from private mortgage insurance premiums and returns on its investment portfolio. Net premiums earned were $245 million, and investment income was $73 million after increasing 11% year over year. This, together with a $37 million reserve release and expense control, resulted in adjusted operating income of $177 million and adjusted diluted earnings per share of $1.26.
Primary insurance in force totaled $274 billion in fiscal Q2 2026, an increase of approximately 2% year over year. The portfolio's weighted average credit score was 746, and its weighted average loan-to-value ratio was 93%, while layered risk represented 1.1% of risk in force. In addition, 88% of delinquent loans had estimated mark-to-market equity of 10% or more, supporting cure rates over the short and medium terms.
Automated analysis for informational purposes only — not investment advice.
Enact raised its targeted capital return range for fiscal 2026 to between $550 million and $600 million, compared with a previous outlook of $500 million. The company returned $127 million during fiscal Q2 2026, including $93 million to repurchase 2.2 million shares and approximately $34 million in dividends. The final amount and form of the return remain dependent on business performance, economic conditions, and regulatory approvals.
Enact launched the Enact Loan Level Assistant, or ELLA, before the August 5, 2026 earnings call. The tool uses generative artificial intelligence to review loan documents, identify inconsistencies, and surface relevant information for underwriters, with the aim of reducing repetitive tasks and improving risk selection. Management said the adoption rate had grown rapidly, but described the rollout as still being in its early stages and did not provide a numerical target for the resulting savings or earnings.
The available analyst consensus is neutral, with an average price target of $46. There is no variation among estimates, as both the highest and lowest targets are $46, making the outlook range extremely narrow. The target is below the 52-week range high of $50.56 and above the low of $34.64, while the data does not provide a price-to-earnings multiple that could be used as an additional valuation metric.